Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dr. Lal PathLabs Limited ( (IN:LALPATHLAB) ) just unveiled an update.
Dr. Lal PathLabs Limited has informed the Indian stock exchanges that its registrar and share transfer agent, MUFG Intime India Private Limited, has issued a certificate confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The filing underscores the company’s adherence to depository-related regulatory requirements, reinforcing its governance and compliance standards for shareholders and market regulators.
More about Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited is an Indian diagnostics company operating in the healthcare services sector, providing pathology and laboratory testing services across the country. The company focuses on medical diagnostic solutions for patients, hospitals, and healthcare providers, and its equity shares are listed on both the National Stock Exchange of India and BSE Limited.
Average Trading Volume: 22,941
Technical Sentiment Signal: Hold
Current Market Cap: 230.8B INR
For a thorough assessment of LALPATHLAB stock, go to TipRanks’ Stock Analysis page.